Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, March 2008, p. 1150-1152, Vol. 52, No. 3
0066-4804/08/$08.00+0 doi:10.1128/AAC.01019-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Sección de Parasitología, Departamento de Bioquímica, Biología Celular y Molecular, Facultad de Farmacia, Universidad San Pablo CEU, Urbanización Montepríncipe, Ctra. Boadilla del Monte km 5,300, 28668 Madrid, Spain,1 Departamento de Parasitología, Facultad de Farmacia, Universidad de Salamanca, Salamanca, Spain2
Received 2 August 2007/ Returned for modification 24 October 2007/ Accepted 16 December 2007
The anticryptosporidial activity of Bobel-24 (2,4,6-triiodophenol) was studied for the first time, resulting in a reduction of the in vitro growth of Cryptosporidium of up to 99.6%. In a SCID mouse model of chronic cryptosporidiosis, significant differences (P < 0.05) in oocyst shedding were observed in animals treated with 125 mg/kg/day. These results merit further investigation of Bobel-24 as a chemotherapeutic option for cryptosporidiosis.
Published ahead of print on 26 December 2007.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»